Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Oct;31(10):1470–1473. doi: 10.1128/aac.31.10.1470

Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.

S D Sears 1, M L Clements 1
PMCID: PMC174973  PMID: 3435099

Abstract

The prophylactic efficacy of a low dose (100 mg) of amantadine hydrochloride against experimental challenge with influenza A/Texas/1/85 (H1N1) wild-type virus was determined in healthy adult volunteers in a placebo-controlled, double-blind, randomized trial. No side effects of the 100-mg dose were observed in the amantadine-treated volunteers. Compared with placebo, 100 mg of amantadine significantly reduced the frequency of illness (9 of 22 versus 2 of 22 volunteers, P less than 0.04) and provided 78% protection against influenza illness. The two ill volunteers in the amantadine group had rhinitis only, whereas most of the ill placebo controls developed both systemic and upper-respiratory-tract illness. Wild-type virus was recovered from 50% of the amantadine-treated volunteers, compared with 82% of the placebo controls. Of note, the infected amantadine recipients shed 100 times less virus and shed virus for half as many days as did the infected placebo recipients. Although amantadine restricted viral replication, it did not interfere with the development of an antibody response to influenza virus. These results indicate that in adults experimentally challenged with influenza wild-type virus, 100 mg of amantadine is effective both in the prevention of influenza illness and in the restriction of virus replication.

Full text

PDF
1470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Couch R. B., Kasel J. A., Glezen W. P., Cate T. R., Six H. R., Taber L. H., Frank A. L., Greenberg S. B., Zahradnik J. M., Keitel W. A. Influenza: its control in persons and populations. J Infect Dis. 1986 Mar;153(3):431–440. doi: 10.1093/infdis/153.3.431. [DOI] [PubMed] [Google Scholar]
  2. Dolin R., Reichman R. C., Madore H. P., Maynard R., Linton P. N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2;307(10):580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  3. Hayden F. G., Hoffman H. E., Spyker D. A. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob Agents Chemother. 1983 Mar;23(3):458–464. doi: 10.1128/aac.23.3.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horadam V. W., Sharp J. G., Smilack J. D., McAnalley B. H., Garriott J. C., Stephens M. K., Prati R. C., Brater D. C. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med. 1981 Apr;94(4 Pt 1):454–458. doi: 10.7326/0003-4819-94-4-454. [DOI] [PubMed] [Google Scholar]
  5. Johnson P. R., Jr, Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 1985 Dec;17(4):325–335. doi: 10.1002/jmv.1890170405. [DOI] [PubMed] [Google Scholar]
  6. Monto A. S., Gunn R. A., Bandyk M. G., King C. L. Prevention of Russian influenza by amantadine. JAMA. 1979 Mar 9;241(10):1003–1007. [PubMed] [Google Scholar]
  7. Muldoon R. L., Stanley E. D., Jackson G. G. Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A. Am Rev Respir Dis. 1976 Apr;113(4):487–491. doi: 10.1164/arrd.1976.113.4.487. [DOI] [PubMed] [Google Scholar]
  8. Murphy B. R., Chalhub E. G., Nusinoff S. R., Kasel J., Chanock R. M. Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J Infect Dis. 1973 Oct;128(4):479–487. doi: 10.1093/infdis/128.4.479. [DOI] [PubMed] [Google Scholar]
  9. Murphy B. R., Clements M. L., Tierney E. L., Black R. E., Stienberg J., Chanock R. M. Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers. J Infect Dis. 1985 Jul;152(1):225–229. doi: 10.1093/infdis/152.1.225. [DOI] [PubMed] [Google Scholar]
  10. Murphy B. R., Nelson D. L., Wright P. F., Tierney E. L., Phelan M. A., Chanock R. M. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun. 1982 Jun;36(3):1102–1108. doi: 10.1128/iai.36.3.1102-1108.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murphy B. R., Phelan M. A., Nelson D. L., Yarchoan R., Tierney E. L., Alling D. W., Chanock R. M. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981 Mar;13(3):554–560. doi: 10.1128/jcm.13.3.554-560.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Payler D. K., Purdham P. A. Influenza A prophylaxis with amantadine in a boarding school. Lancet. 1984 Mar 3;1(8375):502–504. doi: 10.1016/s0140-6736(84)92861-7. [DOI] [PubMed] [Google Scholar]
  13. Rose H. J. Use of amantadine in influenza: a second report. J R Coll Gen Pract. 1983 Oct;33(255):651–653. [PMC free article] [PubMed] [Google Scholar]
  14. Smorodintsev A. A., Karpuhin G. I., Zlydnikov D. M., Malyseva A. M., Svecova E. G., Burov S. A., Hramcova L. M., Romanov J. A., Taros L. J., Ivannikov J. G. The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969. Bull World Health Organ. 1970;42(6):865–872. [PMC free article] [PubMed] [Google Scholar]
  15. Smorodintsev A. A., Zlydnikov D. M., Kiseleva A. M., Romanov J. A., Kazantsev A. P., Rumovsky V. I. Evaluation of amantadine in artificially induced A2 and B influenza. JAMA. 1970 Aug 31;213(9):1448–1454. [PubMed] [Google Scholar]
  16. Van Voris L. P., Betts R. F., Hayden F. G., Christmas W. A., Douglas R. G., Jr Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981 Mar 20;245(11):1128–1131. doi: 10.1001/jama.245.11.1128. [DOI] [PubMed] [Google Scholar]
  17. Younkin S. W., Betts R. F., Roth F. K., Douglas R. G., Jr Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother. 1983 Apr;23(4):577–582. doi: 10.1128/aac.23.4.577. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES